On the public citation graph

Targeting abnormal metabolism in Alzheimer's disease: The Drug Repurposing for Effective Alzheimer's Medicines (DREAM) study

0 signed · 103 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1001/archpsyc.58.12.1161openalex-snapshot
Antipsychotics and the Risk of Sudden Cardiac Death
inferredcites →https://doi.org/10.1001/jamaneurol.2015.4791openalex-snapshot
Association of Proton Pump Inhibitors With Risk of Dementia
inferredcites →https://doi.org/10.1002/9781119413431.ch13openalex-snapshot
Electronic Health Record Databases
inferredcites →https://doi.org/10.1002/bimj.200810488openalex-snapshot
Some Methods of Propensity‐Score Matching had Superior Performance to Others: Results of an Empirical Investigation and Monte Carlo simulations
inferredcites →https://doi.org/10.1002/cpbi.1openalex-snapshot
Using DrugBank for In Silico Drug Exploration and Discovery
inferredcites →https://doi.org/10.1002/cpt.1348openalex-snapshot
Evaluation of Socioeconomic Status Indicators for Confounding Adjustment in Observational Studies of Medication Use
inferredcites →https://doi.org/10.1002/cpt.512openalex-snapshot
Real World Data in Adaptive Biomedical Innovation: A Framework for Generating Evidence Fit for Decision‐Making
inferredcites →https://doi.org/10.1002/pds.1867openalex-snapshot
Multivariate-adjusted pharmacoepidemiologic analyses of confidential information pooled from multiple health care utilization databases
inferredcites →https://doi.org/10.1002/pds.1926openalex-snapshot
A basic study design for expedited safety signal evaluation based on electronic healthcare data
inferredcites →https://doi.org/10.1002/pds.3263openalex-snapshot
One‐to‐many propensity score matching in cohort studies
inferredcites →https://doi.org/10.1002/sim.6058openalex-snapshot
Metrics for covariate balance in cohort studies of causal effects
inferredcites →https://doi.org/10.1002/trc2.12095openalex-snapshot
Targeting abnormal metabolism in Alzheimer's disease: The Drug Repurposing for Effective Alzheimer's Medicines (DREAM) study
inferredcites →https://doi.org/10.1007/s13311-017-0512-4openalex-snapshot
Cilostazol Use Is Associated with Reduced Risk of Dementia: A Nationwide Cohort Study
inferredcites →https://doi.org/10.1007/s40263-016-0374-zopenalex-snapshot
Treatment for Rheumatoid Arthritis and Risk of Alzheimer’s Disease: A Nested Case-Control Analysis
inferredcites →https://doi.org/10.1007/s40264-015-0319-3openalex-snapshot
Benzodiazepine Use and Risk of Developing Alzheimer’s Disease or Vascular Dementia: A Case–Control Analysis
inferredcites →https://doi.org/10.1007/s40471-015-0053-5openalex-snapshot
The Active Comparator, New User Study Design in Pharmacoepidemiology: Historical Foundations and Contemporary Application
inferredcites →https://doi.org/10.1016/j.amjcard.2019.10.043openalex-snapshot
Prevalence and Impact of Having Multiple Barriers to Medication Adherence in Nonadherent Patients With Poorly Controlled Cardiometabolic Disease
inferredcites →https://doi.org/10.1016/j.amjmed.2015.10.015openalex-snapshot
Mining Retrospective Data for Virtual Prospective Drug Repurposing: L-DOPA and Age-related Macular Degeneration
inferredcites →https://doi.org/10.1016/j.bcp.2014.01.002openalex-snapshot
Alzheimer disease therapeutics: Focus on the disease and not just plaques and tangles
inferredcites →https://doi.org/10.1016/j.bcp.2014.01.009openalex-snapshot
The complexities of the pathology–pathogenesis relationship in Alzheimer disease
inferredcites →https://doi.org/10.1016/j.jalz.2013.03.004openalex-snapshot
Validity of dementia and Alzheimer's disease diagnoses in Finnish national registers
inferredcites →https://doi.org/10.1016/j.jalz.2013.11.006openalex-snapshot
Development and validation of a brief dementia screening indicator for primary care
inferredcites →https://doi.org/10.1016/j.jalz.2017.09.011openalex-snapshot
Evidence for brain glucose dysregulation in Alzheimer's disease
inferredcites →https://doi.org/10.1016/j.jclinepi.2004.10.012openalex-snapshot
A review of uses of health care utilization databases for epidemiologic research on therapeutics
inferredcites →https://doi.org/10.1016/j.jclinepi.2010.10.004openalex-snapshot
A combined comorbidity score predicted mortality in elderly patients better than existing scores
inferredcites →https://doi.org/10.1016/j.jclinepi.2016.04.014openalex-snapshot
Specifying a target trial prevents immortal time bias and other self-inflicted injuries in observational analyses
inferredcites →https://doi.org/10.1016/j.jval.2017.08.3019openalex-snapshot
Good Practices for Real‐World Data Studies of Treatment and/or Comparative Effectiveness: Recommendations from the Joint ISPOR‐ISPE Special Task Force on Real‐World Evidence in Health Care Decision Making
inferredcites →https://doi.org/10.1016/j.pharep.2015.07.006openalex-snapshot
Therapeutic strategies for Alzheimer's disease in clinical trials
inferredcites →https://doi.org/10.1016/j.trci.2017.10.002openalex-snapshot
Protective effect of antirheumatic drugs on dementia in rheumatoid arthritis patients
inferredcites →https://doi.org/10.1016/s1474-4422(06)70537-3openalex-snapshot
Risk score for the prediction of dementia risk in 20 years among middle aged people: a longitudinal, population-based study
inferredcites →https://doi.org/10.1016/s1474-4422(13)70044-9openalex-snapshot
Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study
inferredcites →https://doi.org/10.1038/nrd.2018.168openalex-snapshot
Drug repurposing: progress, challenges and recommendations
inferredcites →https://doi.org/10.1038/nrneurol.2015.35openalex-snapshot
Statins, cognition, and dementia—systematic review and methodological commentary
inferredcites →https://doi.org/10.1038/nrrheum.2015.30openalex-snapshot
Active-comparator design and new-user design in observational studies
inferredcites →https://doi.org/10.1038/s41591-020-0815-6openalex-snapshot
Large-scale proteomic analysis of Alzheimer’s disease brain and cerebrospinal fluid reveals early changes in energy metabolism associated with microglia and astrocyte activation
inferredcites →https://doi.org/10.1073/pnas.0701361104openalex-snapshot
The human disease network
inferredcites →https://doi.org/10.1093/aje/154.9.854openalex-snapshot
Performance of Comorbidity Scores to Control for Confounding in Epidemiologic Studies using Claims Data
inferredcites →https://doi.org/10.1093/aje/kwg231openalex-snapshot
Evaluating Medication Effects Outside of Clinical Trials: New-User Designs
inferredcites →https://doi.org/10.1093/aje/kwm070openalex-snapshot
Adherence to Lipid-lowering Therapy and the Use of Preventive Health Services: An Investigation of the Healthy User Effect
inferredcites →https://doi.org/10.1093/aje/kwm324openalex-snapshot
Immortal Time Bias in Pharmacoepidemiology
inferredcites →https://doi.org/10.1093/aje/kwv215openalex-snapshot
Counterpoint: Epidemiology to Guide Decision-Making: Moving Away From Practice-Free Research
inferredcites →https://doi.org/10.1093/biomet/70.1.41openalex-snapshot
The central role of the propensity score in observational studies for causal effects
inferredcites →https://doi.org/10.1093/gerona/glx229openalex-snapshot
Measuring Frailty in Medicare Data: Development and Validation of a Claims-Based Frailty Index
inferredcites →https://doi.org/10.1093/ije/dyv098openalex-snapshot
Data Resource Profile: Clinical Practice Research Datalink (CPRD)
inferredcites →https://doi.org/10.1097/01.wad.0000155068.23937.9bopenalex-snapshot
Does Lithium Therapy Protect Against the Onset of Dementia?
inferredcites →https://doi.org/10.1097/01.wad.0000165511.52746.1fopenalex-snapshot
Association between Dementia and Infectious Disease
inferredcites →https://doi.org/10.1097/ede.0b013e3181a663ccopenalex-snapshot
High-dimensional Propensity Score Adjustment in Studies of Treatment Effects Using Health Care Claims Data
inferredcites →https://doi.org/10.1097/hjh.0000000000000086openalex-snapshot
Angiotension receptor blockers reduce the risk of dementia
inferredcites →https://doi.org/10.1097/mlr.0000000000000729openalex-snapshot
Development of a Claims-based Frailty Indicator Anchored to a Well-established Frailty Phenotype
inferredcites →https://doi.org/10.1097/mlr.0b013e318070c08eopenalex-snapshot
Increasing Levels of Restriction in Pharmacoepidemiologic Database Studies of Elderly and Comparison With Randomized Trial Results
inferredcites →https://doi.org/10.1097/yco.0000000000000041openalex-snapshot
Is there still any hope for amyloid-based immunotherapy for Alzheimer's disease?
inferredcites →https://doi.org/10.1136/bmj.325.7378.1437openalex-snapshot
Data dredging, bias, or confounding
inferredcites →https://doi.org/10.1136/bmj.b5465openalex-snapshot
Use of angiotensin receptor blockers and risk of dementia in a predominantly male population: prospective cohort analysis
inferredcites →https://doi.org/10.1152/ajpcell.00111.2017openalex-snapshot
Understanding mechanisms and seeking cures for Alzheimer's disease: why we must be “extraordinarily diverse”
inferredcites →https://doi.org/10.1161/circulationaha.115.017719openalex-snapshot
Introduction to the Analysis of Survival Data in the Presence of Competing Risks
inferredcites →https://doi.org/10.1186/1471-2296-11-1openalex-snapshot
Adaptation and validation of the Charlson Index for Read/OXMIS coded databases
inferredcites →https://doi.org/10.1186/alzrt269openalex-snapshot
Alzheimer’s disease drug-development pipeline: few candidates, frequent failures
inferredcites →https://doi.org/10.1186/s13024-018-0282-4openalex-snapshot
Deep proteomic network analysis of Alzheimer’s disease brain reveals alterations in RNA binding proteins and RNA splicing associated with disease
inferredcites →https://doi.org/10.1200/jco.2009.24.1877openalex-snapshot
Immortal Person-Time in Studies of Cancer Outcomes
inferredcites →https://doi.org/10.1212/01.wnl.0000219668.47116.e6openalex-snapshot
Neuropathology of older persons without cognitive impairment from two community-based studies
inferredcites →https://doi.org/10.1212/01.wnl.0000279333.77404.d7openalex-snapshot
Association of statin use with cognitive decline in elderly African Americans
inferredcites →https://doi.org/10.1212/wnl.0000000000001774openalex-snapshot
Cognitive impairment 18 years before clinical diagnosis of Alzheimer disease dementia
inferredcites →https://doi.org/10.1212/wnl.0b013e31828726f5openalex-snapshot
Alzheimer disease in the United States (2010–2050) estimated using the 2010 census
inferredcites →https://doi.org/10.1212/wnl.0b013e3182a35228openalex-snapshot
Antihypertensive drugs decrease risk of Alzheimer disease
inferredcites →https://doi.org/10.1371/journal.pmed.1002266openalex-snapshot
Association between fatty acid metabolism in the brain and Alzheimer disease neuropathology and cognitive performance: A nontargeted metabolomic study
inferredcites →https://doi.org/10.1371/journal.pmed.1002482openalex-snapshot
Brain and blood metabolite signatures of pathology and progression in Alzheimer disease: A targeted metabolomics study
inferredcites →https://doi.org/10.1371/journal.pmed.1003012openalex-snapshot
Dysregulation of multiple metabolic networks related to brain transmethylation and polyamine pathways in Alzheimer disease: A targeted metabolomic and transcriptomic study
inferredcites →https://doi.org/10.1371/journal.pone.0229819openalex-snapshot
Tumor Necrosis Factor (TNF) blocking agents are associated with lower risk for Alzheimer’s disease in patients with rheumatoid arthritis and psoriasis
inferredcites →https://doi.org/10.18553/jmcp.2014.20.11.1110openalex-snapshot
Predictors of Treatment Initiation with Tumor Necrosis Factor-α Inhibitors in Patients with Rheumatoid Arthritis
inferredcites →https://doi.org/10.18553/jmcp.2018.24.11.1138openalex-snapshot
Predicting Diagnosis of Alzheimer’s Disease and Related Dementias Using Administrative Claims
inferredcites →https://doi.org/10.2147/cer.s40357openalex-snapshot
A tool for assessing the feasibility of comparative effectiveness research
inferredcites →https://doi.org/10.3233/jad-121819openalex-snapshot
Epidemiology, Co-Morbidities, and Medication Use of Patients with Alzheimer's Disease or Vascular Dementia in the UK
inferredcites →https://doi.org/10.3233/jad-2009-1099openalex-snapshot
The Accuracy of Medicare Claims as an Epidemiological Tool: The Case of Dementia Revisited
inferredcites →https://doi.org/10.3233/jad-2011-101524openalex-snapshot
Incidence of Dementia is Increased in Type 2 Diabetes and Reduced by the Use of Sulfonylureas and Metformin
inferredcites →https://doi.org/10.3390/biomedicines7040097openalex-snapshot
Reasons for Failed Trials of Disease-Modifying Treatments for Alzheimer Disease and Their Contribution in Recent Research
inferredcites →https://doi.org/10.4088/jcp.14m09580openalex-snapshot
Antidepressant Treatment and Risk of Dementia

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.1001/jamainternmed.2025.1251openalex-snapshot
Tiotropium Initiation and Dementia Risk in Chronic Obstructive Pulmonary Disease
inferred← citeshttps://doi.org/10.1001/jamanetworkopen.2022.6567openalex-snapshot
Comparative Risk of Alzheimer Disease and Related Dementia Among Medicare Beneficiaries With Rheumatoid Arthritis Treated With Targeted Disease-Modifying Antirheumatic Agents
inferred← citeshttps://doi.org/10.1002/alz.70503openalex-snapshot
Bisphosphonates and the risk of dementia in patients with osteoporosis or fragility fracture: A population‐based study in Hong Kong
inferred← citeshttps://doi.org/10.1002/cpt.3583openalex-snapshot
Population‐Based Validation Results From the Drug Repurposing for Effective Alzheimer's Medicines (DREAM) Study
inferred← citeshttps://doi.org/10.1002/trc2.12445openalex-snapshot
Baricitinib and tofacitinib off‐target profile, with a focus on Alzheimer's disease
inferred← citeshttps://doi.org/10.1007/s11033-021-06512-9openalex-snapshot
Recent advances on drug development and emerging therapeutic agents for Alzheimer’s disease
inferred← citeshttps://doi.org/10.1016/j.drudis.2022.02.018openalex-snapshot
Recent advances in metabolomics analysis for early drug development
inferred← citeshttps://doi.org/10.1016/j.semarthrit.2021.06.003openalex-snapshot
Trends in incidence of dementia among patients with rheumatoid arthritis: A population-based cohort study
inferred← citeshttps://doi.org/10.1016/j.tem.2023.06.006openalex-snapshot
An epidemiological introduction to human metabolomic investigations
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.2c00335openalex-snapshot
Mechanistic Insights for Drug Repurposing and the Design of Hybrid Drugs for Alzheimer’s Disease
inferred← citeshttps://doi.org/10.1038/s41380-022-01912-0openalex-snapshot
Hydroxychloroquine lowers Alzheimer’s disease and related dementias risk and rescues molecular phenotypes related to Alzheimer’s disease
inferred← citeshttps://doi.org/10.1038/s41598-023-27420-xopenalex-snapshot
Single-cell-led drug repurposing for Alzheimer’s disease
inferred← citeshttps://doi.org/10.1038/s42003-025-07941-zopenalex-snapshot
A personalized metabolic modelling approach through integrated analysis of RNA-Seq-based genomic variants and gene expression levels in Alzheimer’s disease
inferred← citeshttps://doi.org/10.1038/s43587-021-00138-zopenalex-snapshot
Endophenotype-based in silico network medicine discovery combined with insurance record data mining identifies sildenafil as a candidate drug for Alzheimer’s disease
inferred← citeshttps://doi.org/10.1038/s43587-023-00417-xopenalex-snapshot
Comparator choices in pharmacoepidemiology studies of Alzheimer’s disease
inferred← citeshttps://doi.org/10.1093/braincomms/fcac247openalex-snapshot
No association between initiation of phosphodiesterase-5 inhibitors and risk of incident Alzheimer’s disease and related dementia: results from the Drug Repurposing for Effective Alzheimer’s Medicines study
inferred← citeshttps://doi.org/10.1136/bmjopen-2025-114033openalex-snapshot
Association between the use of anti-herpetic drugs and subsequent initiation of Alzheimer’s disease drug treatment: Dutch population-based inception cohort study
inferred← citeshttps://doi.org/10.1177/13872877251376291openalex-snapshot
Real-world observations on neuroinflammation-related drug responses in Alzheimer's disease
inferred← citeshttps://doi.org/10.14283/jpad.2024.78openalex-snapshot
Disease-Modifying Antirheumatic Drugs and Dementia Prevention: A Systematic Review of Observational Evidence in Rheumatoid Arthritis
inferred← citeshttps://doi.org/10.2174/0109298673341391241231054936openalex-snapshot
Transforming Alzheimer's Treatment: Unveiling New Potential with Drug Repurposing Strategies
inferred← citeshttps://doi.org/10.2174/0113816128274618231105173031openalex-snapshot
Recent Updates on the Development of Therapeutics for the Targeted Treatment of Alzheimer’s Disease
inferred← citeshttps://doi.org/10.3233/jad-240680openalex-snapshot
Drug Repurposing for Effective Alzheimer’s Disease Medicines: Existing Methods and Novel Pharmacoepidemiological Approaches
inferred← citeshttps://doi.org/10.3390/bioengineering13060698openalex-snapshot
Centralized Review of Alzheimer’s Disease and Related Dementias Biomedical Repositories and Computational Methods
inferred← citeshttps://doi.org/10.3390/ph18050722openalex-snapshot
The Association Between Herpes Zoster, Antiherpetic Therapies, and Alzheimer’s Disease: A Comprehensive Systematic Review
inferred← citeshttps://doi.org/10.3904/kjim.2023.536openalex-snapshot
Increased risk of dementia in patients with primary Sjogren’s syndrome: a nationwide population-based cohort study
inferred← citeshttps://doi.org/10.7717/peerj.18151openalex-snapshot
The role of transcriptional and epigenetic modifications in astrogliogenesis
showing the first 26 of 27 · page through all 27
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.